Prefilled Syringes Market Growth, Size, Share and Forecast

According to Stratistics MRC, the Global Prefilled Syringes market is accounted for $4.45 billion in 2015 and is expected to reach $11.18 billion by 2022 growing at a CAGR of 14.0% during the forecast period. Rising prevalence of chronic diseases, technological advancements and rising number of biologics are the key factors fueling the market growth. On the other hand, stringent government regulations and high cost of these syringes are hampering the market.

Rising combination therapy is one of the major trends that can be seen in the prefilled syringes. The growing number of self-injection patients and technological advancements is creating new growth opportunities for the players in the prefilled syringes market. North America leads the market owing to increasing demand from the home-based healthcare treatment. Glass-based prefilled syringes commanded the largest market in terms of both volume and revenue owing to the ideal characteristics of the material.

Browse full report with TOC@ https://marketreportscenter.com/reports/328731/prefilled-syringes-global-market-outlook-2015-2022

Some of the key players in the market include Nipro Corporation, West Pharmaceutical Services, Inc., Bespak, Unilife Corporation, Gerresheimer AG, Vetter Pharma International GmbH, Becton, Dickinson & Company, Ypsomed Holding AG, Baxter International Inc., Stevanato Group and Schott AG.

Therapeutic Application Covered:

Hormonal disorders

Oncology

Auto-immune diseases

Diabetes

Anemia

Other Therapeutic Applications

Usage Type Covered:

Specialty prefilled syringes

Conventional prefilled syringes

Safety prefilled syringes

Barrel Type Covered:

Dual chambered

Customized prefilled syringes

Single chambered

Product Type Covered:

Plastic-based Prefilled Syringes

Glass-based Prefilled Syringes

What our report offers:

- Market share assessments for the regional and country level segments

- Market share analysis of the top industry players

- Strategic...